Navigation Links
Reprogramming cells to fight diabetes
Date:2/22/2013

PHILADELPHIA For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, with limited success. The "reprogramming" of related alpha cells into beta cells may one day offer a novel and complementary approach for treating type 2 diabetes. Treating human and mouse cells with compounds that modify cell nuclear material called chromatin induced the expression of beta cell genes in alpha cells, according to a new study that appears online in the Journal of Clinical Investigation.

"This would be a win-win situation for diabetics - they would have more insulin-producing beta cells and there would be fewer glucagon-producing alpha cells," says lead author Klaus H. Kaestner, Ph.D., professor of Genetics and member of the Institute of Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania. Type 2 diabetics not only lack insulin, but they also produce too much glucagon.

Both type 1 and type 2 diabetes are caused by insufficient numbers of insulin-producing beta cells. In theory, transplantation of healthy beta cells for type 1 diabetics in combination with immunosuppression to control autoimmunity - should halt the disease, yet researchers have not yet been able to generate these cells in the lab at high efficiency, whether from embryonic stem cells or by reprogramming mature cell types.

Alpha cells are another type of endocrine cell in the pancreas. They are responsible for synthesizing and secreting the peptide hormone glucagon, which elevates glucose levels in the blood.

"We treated human islet cells with a chemical that inhibits a protein that puts methyl chemical groups on histones, which - among many other effects - leads to removal of some histone modifications that affect gene expression," says Kaestner. "We then found a high frequency of alpha cells that expressed beta-cell markers, and even produced some insulin, after
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. A relationship between cancer genes and the reprogramming gene SOX2 discovered
2. New drug prevents spread of human prostate cancer cells
3. Tiny hitchhikers attack cancer cells
4. To prevent leukemias dreaded return, go for the stem cells
5. Scientists identify major source of cells defense against oxidative stress
6. Therapy exploits addiction of leukemia cells
7. IBN discovers human neural stem cells with tumor targeting ability
8. Leukaemia cells have a remembrance of things past
9. Small molecular bodyguards kill HPV-infected cancer cells by protecting tumor-suppressor
10. Research yields new clues to how brain cancer cells migrate and invade
11. Presence of fetal cells in women lowers risk of breast cancer but raises risk of colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Reprogramming cells to fight diabetes
(Date:8/4/2015)... ... August 04, 2015 , ... Ryadon Inc. will ... Finding reliable hardware can be difficult and troublesome for companies. Without dependable ... or designing a new facility, it is imperative to include only the finest, ...
(Date:8/4/2015)... TX (PRWEB) , ... August 04, 2015 , ... Bayco ... factor small enough to fit, for example, on hard hats that have a flip-up ... Dual-Light Headlamp allows users to work without having to remove their headlamp when ...
(Date:8/4/2015)... ... ... Angelina Jolie is in it at age 39. “It” is menopause, one of ... DO, MBA, CPE aka “Dr. Hot Flash,” arguably the Southwest’s leading authority on ... , Myth #1: Menopause only affects old ladies. – Menopause can affect women of ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... are suffering from underarm sweat. Evolutions Medical & Day Spa in Santa Barbara, ... the only non-invasive, FDA cleared treatment that permanently eliminates sweat and odor glands ...
(Date:8/4/2015)... ... August 04, 2015 , ... PerceptiMed, Inc. ... Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August 1, 2015. ... Dr. Carmona said. "I strongly believe in the mission of the company and ...
Breaking Medicine News(10 mins):Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3
... A unique global conference,focusing on the future ... - 10,2009. The HealthQuake Summit will present an ... and explore the ongoing and future seismic,"tremors" in ... policy, and,science/technology that will make the industry virtually ...
... for Passover, ATLANTA, April 14 As Americans ... Centers for Disease Control,and Prevention advises all travelers to ... a measles outbreak in Israel., Since September, more ... with about 700 cases in the cities of Jerusalem ...
... of needing to start treatment , , MONDAY, April 14 ... antioxidant urate in their blood appear to develop the symptoms ... a new report says. , The findings, published in the ... early laboratory studies about urate,s protective qualities and offer hope ...
... treated , , MONDAY, April 14 (HealthDay News) -- People ... headaches than those with normal blood pressure, a new ... the new research does not mean those with hypertension ... pressure medications. , The stiff arteries that are associated ...
... arthritis (RA) sufferers, the Medicare Prescription Drug Improvement ... better disease management with biologic drugs. Prior to ... of the tumor necrosis factor (TNF) inhibitors, ... brand name, Remicade. Since the MMA, most Medicare ...
... BMW NA, Henry Ford Health System, Kraft Foods ... VitalSpring Award-Winning,Health Benefits Solution to Drive Industry Standards ... HR and Benefits Executives is Scheduled for,April 22nd, ... for Wellness ROI,Inc. announced today that it has ...
Cached Medicine News:Health News:CDC Urges Travelers to Israel to Protect Themselves from Measles 2Health News:Elevated Urate Levels May Slow Parkinson's in Men 2Health News:High Blood Pressure May Be Buffer Against Headaches 2Health News:High Blood Pressure May Be Buffer Against Headaches 3Health News:Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients 2Health News:Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients 3Health News:Alliance for Wellness ROI, Inc. Selects VitalSpring as Exclusive Technology Partner 2Health News:Alliance for Wellness ROI, Inc. Selects VitalSpring as Exclusive Technology Partner 3
(Date:8/4/2015)... LOS ANGELES , Aug. 4, ... ), the world,s leading provider of diagnostic information ... previously announced acquisition of MemorialCare Health System,s laboratory ... result of the transaction, patients and physicians now ... services and network of nearly 200 patient service ...
(Date:8/4/2015)... 2015  The Pittsburgh Life Sciences Greenhouse (PLSG), the ... that one of its portfolio companies, Medrobotics Corporation, has ... Robotic System in the U.S.  ... Medrobotics," said John W. Manzetti , president and ... way since spinning out of The Robotics Institute at ...
(Date:8/4/2015)... Calif., Aug. 4, 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ... million and $18.9 million for the three and six ... net loss of $12.1 million and $43.4 million for ... results were driven primarily by the more than $90 ... related to the upfront payment from Bayer to license  ...
Breaking Medicine Technology:Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
... 2012  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the ... a company overview at Citi,s 2012 Global Health Care Conference ... the Waldorf Astoria in New York City. A ... the "Investors & Media" section of the Company,s Web site, ...
... Feb. 21, 2012   Enanta Pharmaceuticals, Inc. , ... best-in-class small molecule drugs in the infectious disease ... an exclusive collaboration and license agreement with Novartis ... its lead development candidate, EDP-239, from its NS5A ...
Cached Medicine Technology:Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 3
... Healthcare is known as ... analysis programs for every ... device. With advanced programs ... and ACI-TIPI, GE can ...
... The Affinity pacemaker family ... smallest, truly automatic devices. ... combination of advanced technologies ... DR pacemaker incorporates the ...
... Guidant INSIGNIA Ultra pacing ... easy-to-use features for simplified ... patient safety. All INSIGNIA ... using the ZOOM Programming ...
... SDX model 1688 and model 1488 active-fixation ... pacing leads, offering the unsurpassed handling advantages, ... Medical's line of active-fixation leads. Implantable with ... diameter of the Tendril SDX lead is ...
Medicine Products: